8th Annual Cell Culture and Bioprocessing Congress

We will welcome over 350 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture and bioprocessing technologies

4 interactive streams:

Cell Line Development
PART 1: Early Cell Culture and Cell Line Engineering
PART 2: 3D Cell Culture Models and Applications
Process Development: Upstream Bioprocessing and Analytics
Cell Line Development: Late Stage Cell Line Development, Stability, Data and Assay Data Development
Cell Culture and Downstream Bioprocessing
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Co-located with our highly anticipated 6th Annual Stem Cell and Regenerative Medicine Congress, 5th Annual Cell and Gene Therapy Congress and 2nd Biobanking Congress.

Others Details

Brochure: https://go.evvnt.com/395613-3?pid=6581 Speakers: Christine DeMaria, Director, Cell Line Development, Sanofi, Matthew Cheeks, Director of Biopharmaceutical Development, MedImmune, Joachim Bar, Director Cell Culture Development, Boehringer Ingelheim, Sagit Shalel Levanon, Associate Director, Bioprocess Technologies, Teva, Sarah Cox, Associate Director Biotherapeutics, Genomics Institute of the Novartis Research Foundation